Patients and methods
From 2001 to 2003, a total of 1264 patients with EGC underwent cancer resection in the National Cancer Center Hospital (NCCH), Tokyo. We excluded 38 patients who had EGC diagnosed during a pretreatment workup for another malignancy and reviewed the medical records of 1226 patients. We analyzed patients' reported symptoms and the procedures involved in EGC detection, including the motivation for investigation and the initial examinations leading to detection of the cancer. Screening examinations were classified as radiological or endoscopic.
Based on the existence of symptoms, we divided the patients with EGC into two groups -with or without symptoms -and we analyzed the age, sex, and clinical features of each group. We investigated 847 (69.1%) men and 379 (30.9%) women with a mean age of 62.8 years (range 26-95 years). All patients were treated with either surgical or endoscopic resection of the disease in the NCCH. The resected specimens were histologically assessed in detail. In all cases, the adenocarcinoma of stomach was histologically confirmed to be limited to either the mucosa or submucosa irrespective of lymph node involvement [36] .
Statistical analysis
The chi-squared test was used for statistical analysis using a standard computer software statistical package (SPSS for Windows, release 6.0; SPSS, Chicago, IL, USA). P < 0.05 was considered significant.
Results
Of 1226 patients with EGC, 512 patients (41.8%) were symptomatic and 714 (58.2%) had no symptoms. The demographic details of the patients are shown in Table  1 . Univariate analysis showed that the percentage of men was higher in the asymptomatic group than the symptomatic group (P < 0.0001). No significant difference in age between symptomatic and asymptomatic patients was found.
The symptoms and signs of the patients with EGC are shown in detail in Table 2 . Epigastric pain, gastric discomfort, or hunger pain were the most common chief complaints being reported by 376 patients (73.4%) at the detection of EGC.
The procedures for detecting EGC, the motivation for investigations, and the initial examinations are shown in Table 3 and Table 4 , respectively. Of the patients, 788 (64.3%) were examined at outpatient clinics, 345 (28.1%) were investigated by private health assessment clinics, and 93 (7.6%) were participating in the mass screening program. Of the symptomatic patients, 468 (91.4%) were examined at outpatient clinics, 39 (7.6%) were investigated by private health assessment clinics, and 5 (1.0%) were participating in the mass screening program. In contrast, of the asymptomatic patients, 320 (44.8%) were examined at outpatient clinics, 306 (42.9%) were investigated by private health assessment clinics, and 88 (12.3%) were participating in the mass screening program. EGD was the initial assessment in 77.7% of the patients with EGC, and radiography was used in only 22.3%. In total, 91.6 % of the symptomatic patients directly underwent EGD, and radiography was the initial assessment in only 8.4% of them. In contrast, of the asymptomatic patients, EGD was the initial assessment in 67.8%, amd radiography was the initial assessment in only 32.2%.
Discussion
Mass screening for gastric cancer with photofluorography has been widely conducted in Japan since 1960 [8] [9] [10] [11] [12] [13] [14] [15] . With the establishment of the Japanese Society of Gastric Mass Survey in 1962 (later renamed Gastroenterological Mass Survey), the program has spread throughout the country. At present more than 6 million people are screened annually, and the number of gastric cancers detected by screening is increasing. Cohort and case-control studies generally show a decrease in the mortality risk from gastric cancer because of this program [10] .
From the 1980s it became evident that EGD was promising in the earlier detection of gastric cancer because of its ability to detect subtle mucosal abnormalities better than radiography. Its accuracy is higher, and it enables simultaneous biopsy for histological confirmation of malignancy [16] [17] [18] [19] [20] . Nowadays the so-called gastritis-like type of early gastric cancer is increasing in Japan [37, 38] . This type of EGC cannot be identified by radiological investigation, so suspicions of its existence are generated during endoscopy and confirmed only by pathology. Furthermore, earlier detection of gastric malignancies increases the possibility of a successful endoscopic treatment instead of surgery [39] .
Although the positive predictive value of radiographic screening for gastric cancer organized by the government is only 1%-2%, its sensitivity is 70%-90% [10] . Unfortunately, only 20% of the eligible population aged >40 years accept this governmental screening program [40, 41] . On the other hand, it is believed that each year more than 6 million people are examined by either radiography or EGD outside of the mass screening program. According to the Survey of Medical Care Activities in Public Health Insurance 2004 [42] , more than 7.8 million people are examined annually by EGD in Japan. With a population of 85 million >20 years old, 9% of Japanese undergo EGD every year. The explanation for this trend is that endoscopic examination is widely considered to be more accurate for detecting EGC [16] [17] [18] [19] [20] . In our sample, EGD was the initial assessment in most (77.7%) of the patients.
According to the 4th and 5th National Cancer Surveys in Japan [40] , gastric cancer (including the advanced cases) is most commonly detected in outpatient clinics, whereas only 6.0% is identified by the government-based mass screening program and 4.6% by private health assessment clinics. In our cohort of EGC, more patients were diagnosed by the private clinics (28.1%), and the contribution of the mass screening program was less than 10%. Of the asymptomatic patients, only 12.3% participated in the mass screening program; the rest were examined outside of mass screening. Thus, most of the patients with EGC were detected outside the mass screening program regardless of symptoms. In addition, univariate analysis showed that the proportion of men was higher in the asymptomatic group than the symptomatic group. The reason for this discrepancy may be due to the fact that men have greater accessibility to health checkups (including mass screening or private health assessment clinics) at the workplace than women in Japan [17, 24, 26] . The proportion of EGC cases among those of gastric cancer is more than 50% in Japan [8] , whereas in the West the proportion is much lower [43] . In the West, it is widely believed that this difference is due to the mass screening program [2, 31] . However, our study suggests that the reason for the increased detection of EGC in Japan is not only the success of the mass screening program but also the cautious attitude of Japanese people and physicians toward gastric cancer. The awareness of the risk of gastric cancer and the importance of early detection has increased recently, and many individuals attend private health assessment clinics without symptoms [14] . Also, if individuals have symptoms, they generally seek medical consultation at outpatient clinics. Similarly, all physicians perform some kind of investigation to rule out gastric malignancy. This suggests that outpatient clinics or private clinics have a more important role in early detection than mass screening. In this way, in the West the role of mass screening is misunderstood.
This study was conducted in the National Cancer Center Hospital in Tokyo, which is a major referral center in Japan. The background of patients may not represent the rest of the country, as they are usually of higher socioeconomic status. They are more aware of the risk of gastric cancer and the importance of early detection. Therefore, they may attend outpatient clinics or private clinics for endoscopy more frequently. A nationwide project is required in the future to study the true effect of mass screening.
From the aspect of medical science, EGD was promising in the earlier detection of gastric cancer [16] [17] [18] [19] [20] . To detect gastric cancer at an earlier stage and to reduce the mortality due to gastric cancer, mass screening using EGD may be useful screening program. However, no studies have directly examined whether the screening using EGD reduced the mortality due to gastric cancer. Therefore, this endoscopic screening program should be evaluated in terms of the mortality due to gastric cancer. In addition, from the aspect of medical economics, despite its diagnostic advantages, its cost is much higher and it requires more staff and technical expertise compared to radiology [17, 44] . In financial terms, perhaps its economic efficiency is low. Therefore, at this moment mass screening using EGD with governmental support would be beneficial only in a population at high risk for gastric cancer.
Measures similar to those of employed in Japan with an aim of earlier detection of gastric cancer should be considered in the areas with a high incidence of gastric cancer, such as Latin America and eastern Europe [41] .
They may decrease the morbidity and mortality of this formidable disease and improve its dismal prognosis throughout the world.
